期刊文献+

特发性甲状旁腺功能减退症的维生素D受体基因多态性

Vitamin D receptor gene polymorphism of idiopathic hypoparathyroidism patients
下载PDF
导出
摘要 目的探讨特发性甲状旁腺功能减退症(简称特发甲旁减)维生素D受体(VDR)基因3'端多态性分布。方法应用聚合酶链反应-限制性内切酶片段长度多态性分析确定106例特发甲旁减患者VDR基因型。结果VDR基因3'端各多态性位点基因分布符合Hardy-Weinberg群体遗传学定律,与健康志愿者无显著差异(P>0.05),不同基因型特发甲旁减患者身高、体重、BMI和发病年龄无显著差异(P>0.05)。结论未发现中国特发甲旁减患者VDR基因3'端多态性与健康志愿者差异有显著性,不同VDR基因型患者发病年龄及BMI差异无显著性。 【Objective】To investigate the distribution of vitamin D receptor gene 3'-end polymorphisms in idiopathic hypoparathyroidism patients in China.【Methods】 The vitamin D receptor gene 3'-end region genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism in 106 patients of idiopathic hypoparathyroidism.【Results】The frequencies of the genotypes of vitamin D receptor gene 3'-end polymorphism of idiopathic hypoparathyroidism were as follows:allele b:94.3%,allele a:71.2%,and allele T:95.8%.Hardy-Weinberg equilibrium was evident.There was no significant difference about the vitamin D receptor gene 3'-end polymorphism distributions between idiopathic hypoparathyroidism patients and healthy volunteers.No differences in stature,weight,BMI and age of onset of each genotypes were found in idiopathic hypoparathyroidism patients(P0.05).【Conclusions】There was no significant difference about the vitamin D receptor gene 3'-end polymorphism distributions between idiopathic hypoparathyroidism patients and healthy volunteers.No differences in BMI and age of onset of each genotypes were found in idiopathic hypoparathyroidism patients.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第7期1034-1037,共4页 China Journal of Modern Medicine
关键词 维生素D受体 单核苷酸多态性 特发性甲状旁腺功能减退症 vitamin D receptor single nucleotide polymorphisms idiopathic hypoparathyroidism
  • 相关文献

参考文献2

二级参考文献10

  • 1[1]SACHIDANANDAM R,WEISSMAN D,SCHMIDT SC,et al.A map of human genome sequence ariation containing 1.42 million single nucleotide polymorphisms[J].Nature,2001,409:928-933.
  • 2[2]RIVA A,KOHANE IS.SNPper:retrieval and analysis of human SNPs[J].Bioinformatics,2002,18(12):1681-1685.
  • 3[3]MOONEY S.Bioinformatics approaches and resources for single nucleotide polymorphism functional analysis[J].Brief Bioinform,2005,6(1):44-56.
  • 4[4]TAYLOR NE,GREENE EA.PARSESNP:A tool for the analvsis of nucleotide polpmorphisms[J].Nucleic Acids Res,2003,31(13):3808-3811.
  • 5[5]LEE SJ,CHOYS,CHO MC,et al.Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells[J].J Immunol,2001,167(1):497-504
  • 6[6]LEE KA,CHO KJ,KIM SH,et al.IL-18 E42A mutant is resistant to the inhibitory effects of HPV-16 E6 and E7 oncogenes on the IL-18-mediated immune response[J].Cancer Lett,2005,229(2):261-270.
  • 7[7]KALINA U,BALLAS K,KOYAMA N,et al.Genomic organization and regulation of the human interleukin-18 gene[J].Scand J Immunol,2000,52(6):525-530.
  • 8[8]NEBERT D W.Pharmacogenetics and pharm acog enomics:Why is this relevant to the clinical geneticist[J].ClinGenet,1999,56:247-258.
  • 9[9]CARGILL M,ALTSHULER D,IRELGNDJETAL.Characterization of single nucleotide polymorphisms in coding regions of human genes[J].Nature Genetics,1999,22:231-238.
  • 10[10]PUI-YAN KWOK.Single Nucleotide Polymorphisms Methods and Protocols[M].Humama Press Inc,2003:58-62.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部